1. Home
  2. ATON vs GOVX Comparison

ATON vs GOVX Comparison

Compare ATON & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlphaTON Capital Corp. Common Stock

ATON

AlphaTON Capital Corp. Common Stock

N/A

Current Price

$1.46

Market Cap

12.6M

Sector

Energy

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.40

Market Cap

12.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATON
GOVX
Founded
1973
2001
Country
British Virgin Islands
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6M
12.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATON
GOVX
Price
$1.46
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
2.2M
556.6K
Earning Date
11-28-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,353,560.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.52
52 Week Low
$1.41
$0.37
52 Week High
$15.82
$2.75

Technical Indicators

Market Signals
Indicator
ATON
GOVX
Relative Strength Index (RSI) N/A 41.54
Support Level N/A $0.37
Resistance Level N/A $0.43
Average True Range (ATR) 0.00 0.03
MACD 0.00 0.01
Stochastic Oscillator 0.00 43.21

Price Performance

Historical Comparison
ATON
GOVX

About ATON AlphaTON Capital Corp. Common Stock

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: